Huuuge Inc.

Transaction in Own Shares • Apr 1, 2022

Purchaseof own shares under the buy-back program

Huuuge,Inc. ("Issuer"), announces that as part of the realization of the sharebuyback program (RB 4/2022 and RB 9/2022) the Issuer has purchased itsown shares (ISIN code: US44853H1086), as follows:

-on March 29th, 2022 - 18,042 shares of the total value of PLN345,441.01, forthe average unit price of 19.15 PLN, constituting in total 0.02% sharein the share capital and representing 0.02% in of the total number ofshares entitled to vote at the stockholder's meeting,

-on March 30th, 2022 - 24,355 shares of the total value of PLN467,856.05, forthe average unit price of 19.21 PLN, constituting in total 0.03% sharein the share capital and representing 0.03% in the total number ofshares entitled to vote at the stockholder's meeting,

-on March 31st, 2022 - 26,113 shares of the total value of_#160;PLN474,679.52,for the average unit price of 18.18 PLN, constituting in total 0.03%share in the share capital and representing 0.03% in of the total numberof shares entitled to vote at the stockholder's meeting, and

-on April 1st, 2022 - 27,039 shares of the total value of_#160;PLN481,107.24,for the average unit price of_#160; PLN 17.79, constituting in total 0.03%share in the share capital and representing 0.03% in the total number ofshares entitled to vote at the stockholder's meeting.

Thetransactions were executed through Ipopema Securities S.A.

Includingall transactions above the Issuer holds 1,571,127 own shares,constituting 1.86% share in the share capital and representing 1.86% inthe total number of shares entitled to vote at the stockholder's meeting(including treasury shares acquired earlier).

Legalbasis:Article2 Section 2 and 3 of Commission Delegated Regulation (EU) 2016/1052 of 8March 2016 supplementing Regulation (EU) No 596/2014 of the EuropeanParliament and of the Council with regard to regulatory technicalstandards for the conditions applicable to buy-back programmes andstabilisation measures in accordance with Article 5 Section 3 of the MAR.